难治性青光眼患者的房水引流管植入术和平坦部玻璃体切除术

Aqueous tube-shunt implantation and pars plana vitrectomy in eyes with refractory glaucoma.

作者信息

Gandham S B, Costa V P, Katz L J, Wilson R P, Sivalingam A, Belmont J, Smith M

机构信息

William and Anna Goldberg Glaucoma Service, Wills Eye Hospital, Jefferson Medical College, Philadelphia, Pennsylvania 19107.

出版信息

Am J Ophthalmol. 1993 Aug 15;116(2):189-95. doi: 10.1016/s0002-9394(14)71284-x.

DOI:10.1016/s0002-9394(14)71284-x

PMID:8352304

Abstract

We reviewed the surgical outcome of 20 eyes of 20 consecutive patients who had undergone combined aqueous tube-shunt implantation and vitrectomy for complicated glaucoma associated with vitreoretinal disorders. After a mean follow-up of 10.39 +/- 5.43 months, visual acuity remained stable or improved in 13 patients (65%), and intraocular pressure was controlled (< 22 mm Hg) in 15 (75%). The most common complications were corneal edema (seven eyes) and choroidal effusion (three eyes). Combined tube-shunt implantation and pars plana vitrectomy may successfully control intraocular pressure and maintain preoperative visual acuity in refractory glaucoma associated with vitreoretinal disorders.

摘要

我们回顾了20例连续患者的20只眼睛的手术结果，这些患者接受了房水引流管植入联合玻璃体切除术，用于治疗与玻璃体视网膜疾病相关的复杂性青光眼。平均随访10.39±5.43个月后，13例患者（65%）视力保持稳定或提高，15例（75%）眼压得到控制（<22 mmHg）。最常见的并发症是角膜水肿（7只眼）和脉络膜渗漏（3只眼）。房水引流管植入联合玻璃体切除术可能成功控制与玻璃体视网膜疾病相关的难治性青光眼的眼压，并维持术前视力。